Ocrelizumab versus Interferon Beta‐1a in Relapsing Multiple Sclerosis

By Stephen L. Hauser, A. Bar-Or, G. Comi, G. Giovannoni, Hans-Peter Hartung, Bernhard Hemmer, F. Lublin, X. Montalban, K. Rammohan, K. Selmaj and 11 more. New England Journal of Medicine, 2017

1,645 citations recorded by the source corpus.

Subfields: Neurology, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/f37071bf21e5cff76ca89c9e25a9aaa6b820756d